| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |